Ledger.Open graph →

SEC Form D · filed August 3, 2021

Xenetic Biosciences, Inc

Offering

$12.5M

Sold

$12.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

FRAMINGHAM, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Firdaus Dastoor · Framingham, MADirector Alexey Vinogradov · Framingham, MADirector Adam Logal · Framingham, MADirector James Callaway · Framingham, MADirector James Parslow · Framingham, MAExec Curtis Lockshin · Framingham, MAExec Jeffrey Eisenberg · Framingham, MAExec · Director Grigory Borisenko · Framingham, MADirector Roger Kornberg · Framingham, MADirector Volkan Kurtas · Grand Cayman, Cayman IslandsDirector Kimito Iwamoto · Grand Cayman, Cayman IslandsExec Henry Wolf · Pasadena, CADirector Srilatha Charuvu · Milpitas, CAExec David Kafka · Sheridan, WYDirector Moritz Hilf · Grand Cayman, Cayman IslandsExec · Director Keith Dawkins · Pasadena, CADirector Zach Miller · New York, NYDirector Philip M. Darivoff · Grand Cayman, Cayman IslandsDirector Ella A. Sorani · Modi'in, L3Director Steven W. Gfroerer · Ramsey, MNExec Jerome T. Ouimet · St. Paul, MNDirector Edward M. Oleksiak · Flower Mound, TXDirector Teresa L. Sporer · Prairie City, IAExec · Director Christopher C. Boyd · Fairview, TXDirector William Shufelt · Encinitas, CADirector Andrew Christodoulides · New York, NYDirector Robert P. Spider · Boca Raton, FLExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗